WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that a placental growth factor (PlGF) measurement using its DELFIA ® ...
PerkinElmer (UK) Pension Scheme, Beaconsfield, England, insured £130 million ($179 million) in liabilities through a full buy-in with Standard Life, a spokesman for the plan sponsor confirmed. The ...
PerkinElmer, Inc. PKI recently completed its buyout of BioLegend for a total consideration of approximately $5.25 billion. The latest buyout, which is historically the largest for the company, is ...
PerkinElmer (UK) Ltd., and Gilson, Inc., announced a mass spectroscopy (MS) collaboration to support pharmaceutical and biotech scientists. This collaboration will enable the two companies to provide ...
The U.K.’s National Institute for Health and Care Excellence (NICE) has added two placental growth factor (PIGF)-based tests developed by Perkinelmer Inc. to guidance on diagnosing suspected preterm ...
PerkinElmer, a global leader committed to innovating for a healthier world, announced that the company has completed its previously announced acquisition of Oxford Immunotec Global PLC (Oxford ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results